Most Recent

image: Limber LIMS

Limber LIMS

By | January 1, 2013

Using laboratory information management systems (LIMS) to automate and streamline laboratory tasks: three case studies

1 Comment

image: Creative Emulsification

Creative Emulsification

By | November 1, 2012

Enhancing data collection from emulsion PCR reactions: three case studies

0 Comments

image: Enter the Third Dimension

Enter the Third Dimension

By | September 1, 2012

Cell culture goes 3-D with devices that better mimic in vivo conditions.

2 Comments

image: A Little Help from My Friends

A Little Help from My Friends

By | July 1, 2012

How to get the most out of your collaboration with bioinformaticians

2 Comments

image: Move Over, Mother Nature

Move Over, Mother Nature

By | July 1, 2012

Synthetic biologists harness software to design genes and networks.

5 Comments

image: Eyes on Cancer

Eyes on Cancer

By | April 1, 2012

Techniques for watching tumors do their thing

4 Comments

image: Live and In Color

Live and In Color

By | April 1, 2012

How to track RNA in living cells

2 Comments

image: Combing the Cancer Genome

Combing the Cancer Genome

By | March 1, 2012

A guided tour through the main online resources for analyzing cancer genomics data

5 Comments

image: Speak, RNA

Speak, RNA

By | September 1, 2011

A trip through the transcriptome

0 Comments

image: Learning to Become a Tree Hugger

Learning to Become a Tree Hugger

By | August 1, 2011

A guide to free software for constructing and assessing species relationships

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham